Launch week offerEnds in00h00m00s

annual Promonthly Pro

Mingjia Li

Assistant Professor

Ohio State University

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (20)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (21)

Alessandro Di Federico

University of Bologna

ITALY

View details

Jarushka Naidoo

Honorary Senior Lecturer

Royal College of Surgeons in Ireland

IRELAND

View details

Asrar Alahmadi

Associate Professor

Ohio State University

UNITED STATES

View details

María Isabel Loza García

Professor of Pharmacology with tenure

Universidade de Santiago de Compostela

SPAIN

View details

Ankit Mangla

Associate Professor

Case Western Reserve University

UNITED STATES

View details

Arjun Mittra

Assistant Professor

The Ohio State University Comprehensive Cancer Center

UNITED STATES

View details

David J. Pinato

Imperial College London

UNITED KINGDOM

View details

Carlo Genova

Assistant Professor

University of Genoa

ITALY

View details

Pauline Funchain

Stanford University

UNITED STATES

View details

Anil Parwani

Chair

Ohio State University

UNITED STATES

View details

Fabian Acker

University Hospital Frankfurt

GERMANY

View details

Miguel Mosteiro Lamas

Institut Català d'Oncologia

SPAIN

View details

Lingbin Meng

Assistant Professor

The Ohio State University Comprehensive Cancer Center

UNITED STATES

View details

Dan Spakowicz

Assistant Professor

The Ohio State University Comprehensive Cancer Center

UNITED STATES

View details

Andrea De Giglio

University of Bologna

ITALY

View details

Charlotte Lennox

The University of Manchester

UNITED KINGDOM

View details

Alessandro Russo

Humanitas University

ITALY

View details

Bartlomiej Tomasik

Medical University of Gdansk

POLAND

View details

Amin Nassar

Yale University

UNITED STATES

View details

Aakash Desai

University of Alabama, Tuscaloosa

UNITED STATES

View details

Jun Zhang

Professor

University of Kansas Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mingjia Li

Research Interests

Make your next move.

Explore related searches

Articles (20)

Multi-omic characterization of 14q deletion in renal clear cell carcinoma identifies EDNRB as a predictor of immunotherapy response

Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma

Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: A multicenter international retrospective study

Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non-Small-Cell Lung Cancer Treated With Front-Line Immunotherapy-Based Therapies.

Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry

Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity

Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint Inhibitors

Expanding the Understanding of Polymerase Epsilon in Pancreatic Cancer: Immune Checkpoint Inhibitor Response in Polymerase Epsilon P286R–Mutated Metastatic Pancreatic Adenocarcinoma

Brief Report: Central Nervous System Metastases After Chemoradiation Followed by Durvalumab for Unresectable Locally Advanced Nonsmall Cell Lung Cancer

Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patients

Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapy

Trends in Mesothelioma Mortality in the United States Between 1999 and 2020

Trends in Pleural Mesothelioma Incidence and Survival in Metropolitan and Nonmetropolitan Areas in the United States

Tyrosine Kinase Inhibitors Outperform Immune Checkpoint Inhibitors in Bone-Predominant Metastatic Renal Cell Carcinoma: A Multicenter Real-World Analysis

Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530].

Case report: Hypereosinophilia in non-small cell lung cancer

Metastatic Pancreatic Adenocarcinoma: A Rare Case of Successful Checkpoint Inhibitor Monotherapy in High Tumor Mutational Burden With POLE Gene

Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States

A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy

ASSOCIATION BETWEEN PRE-TREATMENT CHEST IMAGING AND IMMUNE CHECKPOINT INHIBITOR PNEUMONITIS IN LUNG CANCER

Collaborators (21)

Alessandro Di Federico

Jarushka Naidoo

Asrar Alahmadi

María Isabel Loza García

Ankit Mangla

Arjun Mittra

David J. Pinato

Carlo Genova

Pauline Funchain

Anil Parwani

Fabian Acker

Miguel Mosteiro Lamas

Lingbin Meng

Dan Spakowicz

Andrea De Giglio

Charlotte Lennox

Alessandro Russo

Bartlomiej Tomasik

Amin Nassar

Aakash Desai

Jun Zhang

Make your next move.